Trials / Unknown
UnknownNCT04360616
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the Ultrasound vs Mammography: a Clinical Noninferiority Trial.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,277 (estimated)
- Sponsor
- The First Affiliated Hospital of the Fourth Military Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To evaluate and compare the sensitivity, specificity, AUC, pathology results of core needle biopsy and surgical pathology results coincidence rate, tumor staging, and DFS (disease-free survival) of US-detected nonpalpable breast cancer vs mammography-detected nonpalpable breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | imaging | perform US and mammography examination |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2020-04-24
- Last updated
- 2022-01-25
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04360616. Inclusion in this directory is not an endorsement.